A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific

References

• Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN. et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1(1):15016. doi:10.1038/nrdp.2015.16.
   PubMedGoogle Scholar
• Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR–5):1–19; quiz CE32–34.
   PubMedGoogle Scholar
• Harbecke R, Cohen JI, Oxman MN. Herpes zoster vaccines. J Infect Dis. 2021;224(12 Suppl 2):S429–442. doi:10.1093/infdis/jiab387.
   PubMedGoogle Scholar
• Goh AEN, Choi EH, Chokephaibulkit K, Choudhury J, Kuter B, Lee PI, Marshall H, Kim JO, Wolfson LJ. Burden of varicella in the Asia-Pacific region: a systematic literature review. Expert Rev Vaccines. 2019;18(5):475–93. doi:10.1080/14760584.2019.1594781.
   PubMed Web of Science ®Google Scholar
• United Nations Economic and Social Commission for Asia and the Pacific. Addressing the challenges of population ageing in Asia and the Pacific. 2017. Retrieved from https://www.unescap.org/sites/default/files/publications/Addressing%20the%20Challenges%20of%20Population%20Ageing%20in%20Asia%20and%20the%20Pacific.pdf. Accessed November 2023.
   Google Scholar
• Chen LK, Arai H, Chen LY, Chou MY, Djauzi S, Dong B, Kojima T, Kwon KT, Leong HN, Leung EMF, et al. Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific. BMC Infect Dis. 2017;17(1):213. doi:10.1186/s12879-017-2198-y.
   PubMedGoogle Scholar
• U.S. Food & Drug Administration. Package insert for live zoster vaccine Zostavax. 2019. Retrieved from https://www.fda.gov/vaccines-blood-biologics/vaccines/zostavax. Accessed November 2023.
   Google Scholar
• Hales CM, Harpaz R, Ortega-Sanchez I, Bialek SR. Update on recommendations for use of herpes zoster vaccine. MMWR Morb Mortal Wkly Rep. 2014;63(33):729–31.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices. June 2011 Summary Report. 2011. Retrieved from: https://www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-jun11.pdf. Accessed October 2023.
   Google Scholar
• Pan CX, Lee MS, Nambudiri VE. Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review. Ther Adv Vaccines Immunother. 2022;10:25151355221084535. doi:10.1177/25151355221084535.
   Google Scholar
• U.S. Food & Drug Administration. Package insert for recombinant zoster vaccine Shingrix. 2023. Retrieved from https://www.fda.gov/vaccines-blood-biologics/vaccines/shingrix. Accessed November 2023.
   Google Scholar
• Japan Pharmaceuticals and Medical Devices Agency. Package insert for recombinant zoster vaccine Shingrix. 2020. Retrieved from https://www.pmda.go.jp/PmdaSearch/iyakuDetail/GeneralList/631341B. Accessed November 2023.
   Google Scholar
• San Martin P, Aunhachoke K, Batac MCF, Lodrono-Lim K, Kwanthitinan C, Santoso D, Fonseka T, Nguyen M, Guzman-Holst A. Systematic literature review of herpes zoster disease burden in Southeast Asia. Infect Dis Ther. 2023;12(6):1553–78. doi:10.1007/s40121-023-00822-0.
   PubMed Web of Science ®Google Scholar
• Curran D, Callegaro A, Fahrbach K, Neupane B, Vroling H, van Oorschot D, Yawn BP. Meta-regression of herpes zoster incidence worldwide. Infect Dis Ther. 2022;11(1):389–403. doi:10.1007/s40121-021-00567-8.
   PubMed Web of Science ®Google Scholar
• van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B. A systematic literature review of herpes zoster incidence worldwide. Hum Vaccin Immunother. 2021;17(6):1714–32. doi:10.1080/21645515.2020.1847582.
   PubMed Web of Science ®Google Scholar
• International Monetary Fund. Regional Economic Outlook: Asia and Pacific 2021. Retrieved from https://www.imf.org/en/Publications/REO/APAC/Issues/2021/10/15/regional-economic-outlook-for-asia-and-pacific-october-2021. Accessed November 2023.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9. doi:10.1016/j.ijsu.2014.07.013.
   PubMed Web of Science ®Google Scholar
• The World Bank. Data bank: inflation, consumer prices (annual %). 2023. Retrieved from https://data.worldbank.org/indicator/FP.CPI.TOTL.ZG. Accessed October 2023.
   Google Scholar
• United Nations Conference on Trade and Development. Data bank: currency exchange rates, annual (July 2023). Retrieved from https://unctadstat.unctad.org/datacentre/dataviewer/US.ExchangeRateCrosstab. Accessed October 2023.
   Google Scholar
• Liu B, Heywood AE, Reekie J, Banks E, Kaldor JM, McIntyre P, Newall AT, Macintyre CR. Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study. Epidemiol Infect. 2015;143(13):2871–81. doi:10.1017/s0950268814003653.
   PubMed Web of Science ®Google Scholar
• Lin J, Dobbins T, Wood JG, Bernardo C, Stocks NP, Liu B. Impact of a national immunisation program on herpes zoster incidence in Australia. J Infect. 2022;84(4):537–41. doi:10.1016/j.jinf.2022.01.011.
   PubMed Web of Science ®Google Scholar
• Lin J, Dobbins T, Wood JG, Bernardo C, Stocks NP, Liu B. Effectiveness of the live-attenuated herpes zoster vaccine 2 years after its introduction in Australia. Vaccine. 2021;39(10):1493–8. doi:10.1016/j.vaccine.2021.01.067.
   PubMed Web of Science ®Google Scholar
• Li ZW, Yin CN, Wang HT, Du WY, Wang WJ, Xue FZ, Zhao L, Cao WC. Incidence trend and disease burden of seven vaccine-preventable diseases in Shandong province, China, 2013-2017: findings from a population-based observational study. Vaccine. 2022;10:100145. doi:10.1016/j.jvacx.2022.100145.
   Web of Science ®Google Scholar
• Shiraki K, Toyama N, Daikoku T, Yajima M. Herpes zoster and recurrent herpes zoster. Open Forum Infect Dis. 2017;4(1):ofx007. doi:10.1093/ofid/ofx007.
   PubMed Web of Science ®Google Scholar
• Sato K, Adachi K, Nakamura H, Asano K, Watanabe A, Adachi R, Kiuchi M, Kobayashi K, Matsuki T, Kaise T. et al. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: results from an observational, prospective, physician practice-based cohort study. J Dermatol. 2017;44(4):414–22. doi:10.1111/1346-8138.13639.
   PubMed Web of Science ®Google Scholar
• Takao Y, Miyazaki Y, Okeda M, Onishi F, Yano S, Gomi Y, Ishikawa T, Okuno Y, Mori Y, Asada H. et al. Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a community-based prospective cohort study: the SHEZ study. J Epidemiol. 2015;25(10):617–25. doi:10.2188/jea.JE20140210.
   PubMed Web of Science ®Google Scholar
• Shiraki K, Toyama N, Tanaka K, Ito A, Yamamoto J. Effect of universal varicella vaccination and behavioral changes against coronavirus disease 2019 pandemic on the incidence of herpes zoster. J Dermatol Sci. 2021;104(3):185–92. doi:10.1016/j.jdermsci.2021.10.007.
   PubMed Web of Science ®Google Scholar
• Toyama N, Shiraki K. Epidemiology of herpes zoster and its relationship to varicella in Japan: a 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture. J Med Virol. 2009;81(12):2053–8. doi:10.1002/jmv.21599.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Lee CN, Lim CY, Jeon WS, Park YM. Population-based study of the epidemiology of herpes zoster in Korea. J Korean Med Sci. 2014;29(12):1706–10. doi:10.3346/jkms.2014.29.12.1706.
   PubMed Web of Science ®Google Scholar
• Kwon SU, Yun SC, Kim MC, Kim BJ, Lee SH, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH. Risk of stroke and transient ischaemic attack after herpes zoster. Clin Microbiol Infect. 2016;22(6):542–8. doi:10.1016/j.cmi.2016.03.003.
   PubMed Web of Science ®Google Scholar
• Bae S, Yun SC, Kim MC, Yoon W, Lim JS, Lee SO, Choi SH, Kim YS, Woo JH, Kim SY. et al. Association of herpes zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study. Eur Arch Psychiatry Clin Neurosci. 2021;271(5):987–97. doi:10.1007/s00406-020-01157-4.
   PubMed Web of Science ®Google Scholar
• Chao DY, Chien YZ, Yeh YP, Hsu PS, Lian IB. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008. Epidemiol Infect. 2012;140(6):1131–40. doi:10.1017/s0950268811001786.
   PubMed Web of Science ®Google Scholar
• MacIntyre R, Stein A, Harrison C, Britt H, Mahimbo A, Cunningham A, Thompson R. Increasing trends of herpes zoster in Australia. PloS One. 2015;10(4):e0125025. doi:10.1371/journal.pone.0125025.
   PubMed Web of Science ®Google Scholar
• Sheel M, Beard F, Quinn H, Dey A, Kirk M, Koehler A, Markey P, McIntyre P, Macartney K. Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998-2015. Commun Dis Intell. 2018;42:S2209–6051(2218)00002–00007.
   Google Scholar
• Carville KS, Riddell MA, Kelly HA. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine. 2010;28(13):2532–8. doi:10.1016/j.vaccine.2010.01.036.
   PubMed Web of Science ®Google Scholar
• Heywood AE, Wang H, Macartney KK, McIntyre P. Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bull World Health Organ. 2014;92(8):593–604. doi:10.2471/blt.13.132142.
   PubMed Web of Science ®Google Scholar
• Sheel M, Beard FH, Dey A, Macartney K, McIntyre PB. Rates of hospitalisation for herpes zoster may warrant vaccinating Indigenous Australians under 70. Med J Aust. 2017;207(9):395–6. doi:10.5694/mja16.01468.
   PubMed Web of Science ®Google Scholar
• Toyama N, Shiraki K. Universal varicella vaccination increased the incidence of herpes zoster in the child-rearing generation as its short-term effect. J Dermatol Sci. 2018;92(1):89–96. doi:10.1016/j.jdermsci.2018.07.003.
   PubMed Web of Science ®Google Scholar
• Kuniyoshi Y, Tokutake H, Takahashi N, Kamura A, Yasuda S, Tashiro M. Routine varicella vaccination program and hospitalization for herpes zoster in Japan. Hum Vaccin Immunother. 2021;17(11):4171–6. doi:10.1080/21645515.2021.1971014.
   PubMed Web of Science ®Google Scholar
• Choi JK, Park SH, Park S, Cho SY, Lee HJ, Kim SH, Choi SM, Lee DG, Choi JH, Yoo JH. The changing epidemiology of herpes zoster over a decade in South Korea, 2006-2015. Vaccine. 2019;37(36):5153–60. doi:10.1016/j.vaccine.2019.07.086.
   PubMed Web of Science ®Google Scholar
• Choi JK, Park SH, Park S, Choi SM, Kim SH, Lee DG, Yoo JH, Choi JH, Kang JH. Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015. Hum Vaccin Immunother. 2019;15(11):2554–60. doi:10.1080/21645515.2019.1603985.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Lee CN, Lee MS, Lee JH, Lee JY, Han K, Park YM. Recurrence rate of herpes zoster and its risk factors: a population-based cohort study. J Korean Med Sci. 2019;34(2):e1. doi:10.3346/jkms.2019.34.e1.
   PubMed Web of Science ®Google Scholar
• Choi WS, Noh JY, Huh JY, Jo YM, Lee J, Song JY, Kim WJ, Cheong HJ. Disease burden of herpes zoster in Korea. J Clin Virol. 2010;47(4):325–9. doi:10.1016/j.jcv.2010.01.003.
   PubMed Web of Science ®Google Scholar
• Turner NM, MacRae J, Nowlan ML, McBain L, Stubbe MH, Dowell A. Quantifying the incidence and burden of herpes zoster in New Zealand general practice: a retrospective cohort study using a natural language processing software inference algorithm. BMJ Open. 2018;8(5):e021241. doi:10.1136/bmjopen-2017-021241.
   PubMed Web of Science ®Google Scholar
• Lu WH, Lin CW, Wang CY, Chen LK, Hsiao FY. Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study. BMC Public Health. 2018;18(1):369. doi:10.1186/s12889-018-5247-6.
   PubMed Web of Science ®Google Scholar
• Jih JS, Chen YJ, Lin MW, Chen YC, Chen TJ, Huang YL, Chen CC, Lee DD, Chang YT, Wang WJ. et al. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Acta Derm Venereol. 2009;89(6):612–6. doi:10.2340/00015555-0729.
   PubMed Web of Science ®Google Scholar
• Wu PY, Wu HD, Chou TC, Sung FC. Varicella vaccination alters the chronological trends of herpes zoster and varicella. PloS One. 2013;8(10):e77709. doi:10.1371/journal.pone.0077709.
   PubMed Web of Science ®Google Scholar
• Lin YH, Huang LM, Chang IS, Tsai FY, Lu CY, Shao PL, Chang LY. Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan. Vaccine. 2010;28(5):1217–20. doi:10.1016/j.vaccine.2009.11.029.
   PubMed Web of Science ®Google Scholar
• Qian J, Macartney K, Heywood AE, Sheridan S, Liu B. Risk of recurrent herpes zoster in a population-based cohort study of older adults. J Am Acad Dermatol. 2021;85(3):611–8. doi:10.1016/j.jaad.2020.06.1013.
   PubMed Web of Science ®Google Scholar
• Stein AN, Britt H, Harrison C, Conway EL, Cunningham A, Macintyre CR. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine. 2009;27(4):520–9. doi:10.1016/j.vaccine.2008.11.012.
   PubMed Web of Science ®Google Scholar
• Lu L, Suo L, Li J, Pang X. A retrospective survey on herpes zoster disease burden and characteristics in Beijing, China. Hum Vaccin Immunother. 2018;14(11):2632–5. doi:10.1080/21645515.2018.1489193.
   PubMed Web of Science ®Google Scholar
• Li Y, An Z, Yin D, Liu Y, Huang Z, Xu J, Ma Y, Tu Q, Li Q, Wang H. et al. Disease burden due to herpes zoster among population aged ≥50 years old in China: a community based retrospective survey. PloS One. 2016;11(4):e0152660. doi:10.1371/journal.pone.0152660.
   PubMed Web of Science ®Google Scholar
• Sun X, Wei Z, Lin H, Jit M, Li Z, Fu C. Incidence and disease burden of herpes zoster in the population aged ≥50 years in China: data from an integrated health care network. J Infect. 2021;82(2):253–60. doi:10.1016/j.jinf.2020.12.013.
   PubMed Web of Science ®Google Scholar
• Reid JS, Ah Wong B. Herpes zoster (shingles) at a large New Zealand general practice: incidence over 5 years. N Z Med J. 2014;127:56–60.
   PubMedGoogle Scholar
• Wu CY, Hu HY, Huang N, Pu CY, Shen HC, Chou YJ. Do the health-care workers gain protection against herpes zoster infection? A 6-year population-based study in Taiwan. J Dermatol. 2010;37(5):463–70. doi:10.1111/j.1346-8138.2010.00804.x.
   PubMed Web of Science ®Google Scholar
• Ban J, Takao Y, Okuno Y, Mori Y, Asada H, Yamanishi K, Iso H. Association of cigarette smoking with a past history and incidence of herpes zoster in the general Japanese population: the SHEZ study. Epidemiol Infect. 2017;145(6):1270–5. doi:10.1017/s0950268816003174.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Miyagawa F, Okazaki A, Okuno Y, Mori Y, Iso H, Yamanishi K, Asada H. Clinical and immunologic features of recurrent herpes zoster (HZ). J Am Acad Dermatol. 2016;75(5):950–6.e951. doi:10.1016/j.jaad.2016.05.037.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zheng H, Qu H, Deng H, Zhang J, Ma W, Lin Y, Xie X, Qiu Q, Huang Z. Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China. Hum Vaccin Immunother. 2015;11(8):2113–8. doi:10.1080/21645515.2015.1016672.
   PubMed Web of Science ®Google Scholar
• Nelson MR, Britt HC, Harrison CM. Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine. Med J Aust. 2010;193(2):110–13. doi:10.5694/j.1326-5377.2010.tb03818.x.
   PubMed Web of Science ®Google Scholar
• Kelly HA, Grant KA, Gidding H, Carville KS. Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012. Euro Surveill. 2014;19(41). doi:10.2807/1560-7917.es2014.19.41.20926.
   Google Scholar
• Chilver M, Blakeley D, Stocks N. The Australian sentinel practices research network, 1 January to 31 March 2017. Commun Dis Intell Q Rep. 2017;41(4):E492–6.
   PubMedGoogle Scholar
• Chilver MB, Blakeley D, Stocks NP. The Australian sentinel practices research network, 1 October to 31 December 2016. Commun Dis Intell Q Rep. 2017;41(1):E111–3.
   PubMedGoogle Scholar
• Chilver MB, Blakeley D, Stocks NP. Australian sentinel practices research network, 1 October to 31 December 2015. Commun Dis Intell Q Rep. 2016;40(1):E182–4.
   PubMedGoogle Scholar
• Chilver MB, Blakeley D, Stocks NP. Australian sentinel practices research network, 1 July to 30 September 2015. Commun Dis Intell Q Rep. 2015;39(4):E632–4.
   PubMedGoogle Scholar
• Chilver MB, Blakeley D, Stocks NP. Australian sentinel practices research network, 1 October to 31 December 2013. Commun Dis Intell Q Rep. 2015;39(1):E169–71.
   PubMedGoogle Scholar
• Jardine A, Conaty SJ, Vally H. Herpes zoster in Australia: evidence of increase in incidence in adults attributable to varicella immunization? Epidemiol Infect. 2011;139(5):658–65. doi:10.1017/s0950268810001949.
   PubMed Web of Science ®Google Scholar
• Chan DYW, Edmunds WJ, Chan HL, Chan V, Lam YCK, Thomas SL, van Hoek AJ, Flasche S. The changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014. Epidemiol Infect. 2018;146(6):723–34. doi:10.1017/s0950268818000444.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Mizukami A, Adachi K, Matthews S, Holl K, Asano K, Watanabe A, Adachi R, Kiuchi M, Kobayashi K, et al. Economic burden of herpes zoster and post-herpetic neuralgia in adults 60 years of age or older: results from a prospective, physician practice-based cohort study in Kushiro, Japan. Drugs Real World Outcomes. 2017;4(4):187–98. doi:10.1007/s40801-017-0119-4.
   PubMedGoogle Scholar
• Imafuku S, Matsuki T, Mizukami A, Goto Y, de Souza S, Jégou C, Bianco V, Rosillon D, Ito C, Curran D. et al. Burden of herpes zoster in the Japanese population with immunocompromised/chronic disease conditions: results from a cohort study claims database from 2005-2014. Dermatol Ther (Heidelb). 2019;9(1):117–33. doi:10.1007/s13555-018-0268-8.
   PubMed Web of Science ®Google Scholar
• Ming WK, Yu WY, Tsang OT, Chan PK, You JH. Economic analysis of herpes zoster in a hospital setting in Hong Kong. Acta Derm Venereol. 2019;99(6):616–7. doi:10.2340/00015555-3118.
   PubMed Web of Science ®Google Scholar
• MacIntyre CR, Chu CP, Burgess MA. Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia. Epidemiol Infect. 2003;131(1):675–82. doi:10.1017/s0950268803008690.
   PubMed Web of Science ®Google Scholar
• Kim SH, Choi SM, Kim BC, Choi KH, Nam TS, Kim JT, Lee SH, Park MS, Kim SJ. Risk factors for aseptic meningitis in herpes zoster patients. Ann Dermatol. 2017;29(3):283–7. doi:10.5021/ad.2017.29.3.283.
   PubMed Web of Science ®Google Scholar
• Ishikawa Y, Nakano K, Tokutsu K, Nakayamada S, Matsuda S, Fushimi K, Tanaka Y. Short-term prognostic factors in hospitalized herpes zoster patients and its associated cerebro-cardiovascular events: a nationwide retrospective cohort in Japan. Front Med. 2022;9:843809. doi:10.3389/fmed.2022.843809.
   Web of Science ®Google Scholar
• Chen Q, Hsu T-Y, Chan R, Kawai K, Acosta CJ, Walia A, Pan JY. Clinical and economic burden of herpes zoster and postherpetic neuralgia in patients from the National Skin Centre, Singapore. Dermatol Sin. 2015;33(4):201–5. doi:10.1016/j.dsi.2015.04.002.
   Web of Science ®Google Scholar
• Lee SM, Han J, Yang CM, Choi CY, Khoramnia R, Chung TY, Lim DH. Chronic and recurrent herpes zoster ophthalmicus. Medicina (Kaunas). 2021;57(10):999. doi:10.3390/medicina57100999.
   PubMed Web of Science ®Google Scholar
• Wei S, Li X, Wang H, Liu Q, Shao L. Analysis of the risk factors for postherpetic neuralgia. Dermatology. 2019;235(5):426–33. doi:10.1159/000500482.
   PubMed Web of Science ®Google Scholar
• Imafuku S, Nakayama J, Higa K, Furue M, Takahara M, Katayama I, Tani M. One-year follow-up of zoster-associated pain in 764 immunocompetent patients with acute herpes zoster treated with famciclovir (FAMILIAR study). J Eur Acad Dermatol Venereol. 2014;28(12):1716–22. doi:10.1111/jdv.12379.
   PubMed Web of Science ®Google Scholar
• Wang, XX, Zhang Y, Fan, BF. Predicting postherpetic neuralgia in patients with herpes zoster by machine learning: a retrospective study. Pain Ther. 2020;9(2):627–35. doi:10.1007/s40122-020-00196-y.
   PubMed Web of Science ®Google Scholar
• Lin SM, Wang CY, Chen YY, Wang JH, Liang CC, Huang HK. Herpes zoster and the risks of osteoporosis and fracture: a nationwide cohort study. Eur J Clin Microbiol Infect Dis. 2019;38(2):365–72. doi:10.1007/s10096-018-3436-y.
   PubMed Web of Science ®Google Scholar
• Yamada K, Kubota Y, Shimizu Y, Cui R, Mori Y, Okuno Y, Asada H, Yamanishi K, Iso H. Sleep shortage is associated with postherpetic neuralgia development through hyperesthesia and acute pain intensity: a community-based prospective cohort study. Pain Pract. 2019;19(5):476–83. doi:10.1111/papr.12766.
   PubMed Web of Science ®Google Scholar
• Xing X, Sun K, Yan M. Delayed initiation of supplemental pain management is associated with postherpetic neuralgia: a retrospective study. Pain Physician. 2020;23(1):65–72. doi:10.36076/ppj.2020/23/65.
   PubMed Web of Science ®Google Scholar
• Tsai TF, Yao CA, Yu HS, Lan CC, Chao SC, Yang JH, Yang KC, Chen CY, White RR, Psaradellis E. et al. Herpes zoster-associated severity and duration of pain, health-related quality of life, and healthcare utilization in Taiwan: a prospective observational study. Int J Dermatol. 2015;54(5):529–36. doi:10.1111/ijd.12484.
   PubMed Web of Science ®Google Scholar
• Cho SI, Lee CH, Park GH, Park CW, Kim HO. Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study. J Pain. 2014;15(2):149–56. doi:10.1016/j.jpain.2013.10.006.
   PubMed Web of Science ®Google Scholar
• Kawai K, Rampakakis E, Tsai TF, Cheong HJ, Dhitavat J, Covarrubias AO, Yang L, Cashat-Cruz M, Monsanto H, Johnson K. et al. Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia. Int J Infect Dis. 2015;34:126–31. doi:10.1016/j.ijid.2015.03.022.
   PubMed Web of Science ®Google Scholar
• Kim YN, Kim DW, Kim ED. Efficacy of continuous epidural block in acute herpes zoster: incidence and predictive factors of postherpetic neuralgia, a retrospective single-center study. Medicine (Baltimore). 2016;95(32):e4577. doi:10.1097/md.0000000000004577.
   PubMed Web of Science ®Google Scholar
• Wu CH, Chai CY, Tung YC, Lu YY, Su YF, Tsai TH, Tzou RD, Lin CL. Herpes zoster as a risk factor for osteoporosis: a 15-year nationwide population-based study. Medicine (Baltimore). 2016;95(25):e3943. doi:10.1097/md.0000000000003943.
   PubMed Web of Science ®Google Scholar
• Kurokawa I, Kumano K, Murakawa K. Clinical correlates of prolonged pain in Japanese patients with acute herpes zoster. J Int Med Res. 2002;30(1):56–65. doi:10.1177/147323000203000109.
   PubMed Web of Science ®Google Scholar
• Herr H. Prognostic factors of postherpetic neuralgia. J Korean Med Sci. 2002;17(5):655–9. doi:10.3346/jkms.2002.17.5.655.
   PubMed Web of Science ®Google Scholar
• Niederer RL, Meyer JJ, Liu K, Danesh-Meyer HV. Herpes zoster ophthalmicus clinical presentation and risk factors for loss of vision. Am J Ophthalmol. 2021;226:83–9. doi:10.1016/j.ajo.2021.02.002.
   PubMed Web of Science ®Google Scholar
• Szeto SK, Chan TC, Wong RL, Ng AL, Li EY, Jhanji V. Prevalence of ocular manifestations and visual outcomes in patients with herpes zoster ophthalmicus. Cornea. 2017;36(3):338–42. doi:10.1097/ico.0000000000001046.
   PubMed Web of Science ®Google Scholar
• Tang J, Tao J, Luo G, Zhu J, Yao M. Analysis of risk factors and construction of a prediction model of motor dysfunction caused by limb herpes zoster. J Pain Res. 2022;15:367–75. doi:10.2147/jpr.S346564.
   PubMed Web of Science ®Google Scholar
• Johnson RW, Rice AS. Clinical practice. postherpetic neuralgia. N Engl J Med. 2014;371(16):1526–33. doi:10.1056/NEJMcp1403062.
   PubMed Web of Science ®Google Scholar
• Hong MJ, Kim YD, Cheong YK, Park SJ, Choi SW, Hong HJ. Epidemiology of postherpetic neuralgia in Korea: an electronic population health insurance system based study. Medicine (Baltimore). 2016;95(14):e3304. doi:10.1097/md.0000000000003304.
   PubMed Web of Science ®Google Scholar
• Bang S, Kim YS, Lee S, Park U, Kim TK, Choi Y. Prevalence of common causes of neuropathic pain in Korea: population-based observational study. J Int Med Res. 2020;48(7):300060519888102. doi:10.1177/0300060519888102.
   PubMed Web of Science ®Google Scholar
• Mizukami A, Sato K, Adachi K, Matthews S, Holl K, Matsuki T, Kaise T, Curran D. Impact of herpes zoster and post-herpetic neuralgia on health-related quality of life in Japanese adults aged 60 years or older: results from a prospective, observational cohort study. Clin Drug Investig. 2018;38(1):29–37. doi:10.1007/s40261-017-0581-5.
   PubMed Web of Science ®Google Scholar
• Takao Y, Okuno Y, Mori Y, Asada H, Yamanishi K, Iso H. Associations of perceived mental stress, sense of purpose in life, and negative life events with the risk of incident herpes zoster and postherpetic neuralgia: the SHEZ study. Am J Epidemiol. 2018;187(2):251–9. doi:10.1093/aje/kwx249.
   PubMed Web of Science ®Google Scholar
• Karki S, Newall AT, MacIntyre CR, Heywood AE, McIntyre P, Banks E, Liu B. Healthcare resource utilisation associated with herpes zoster in a prospective cohort of older Australian adults. PloS One. 2016;11(8):e0160446. doi:10.1371/journal.pone.0160446.
   PubMed Web of Science ®Google Scholar
• Yu SY, Fan BF, Yang F, DiBonaventura M, Chen YX, Li RY, King-Concialdi K, Kudel I, Hlavacek P, Hopps M. et al. Patient and economic burdens of postherpetic neuralgia in China. Clinicoecon Outcomes Res. 2019;11:539–50. doi:10.2147/ceor.S203920.
   PubMed Web of Science ®Google Scholar
• Hashizume H, Nakatani E, Sato Y, Goto H, Yagi H, Miyachi Y. A new susceptibility index to predict the risk of severe herpes zoster-associated pain: a Japanese regional population-based cohort study, the Shizuoka study. J Dermatol Sci. 2022;105(3):170–5. doi:10.1016/j.jdermsci.2022.02.006.
   PubMed Web of Science ®Google Scholar
• Cheong C, Lee TJ. Prevalence and healthcare utilization of herpes zoster and postherpetic neuralgia in South Korea: disparity among patients with different immune statuses. Epidemiol Health. 2014;36:e2014012. doi:10.4178/epih/e2014012.
   PubMedGoogle Scholar
• Choi WS, Kwon SS, Lee J, Choi SM, Lee JS, Eom JS, Sohn JW, Choeng HJ. Immunity and the burden of herpes zoster. J Med Virol. 2014;86(3):525–30. doi:10.1002/jmv.23830.
   PubMed Web of Science ®Google Scholar
• Song H, Lee J, Lee M, Choi WS, Choi JH, Lee MS, Hashemi M, Rampakakis E, Kawai K, White R. et al. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study. Int J Infect Dis. 2014;20:23–30. doi:10.1016/j.ijid.2013.11.018.
   PubMed Web of Science ®Google Scholar
• Honda M, Murata T, Ebata N, Fujii K, Ogawa S. Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: analysis of Japanese claims data provided by Japan medical data center. J Dermatol. 2017;44(7):767–73. doi:10.1111/1346-8138.13784.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341–9. doi:10.4065/82.11.1341.
   PubMed Web of Science ®Google Scholar
• Harpaz R, Leung JW. The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among older adults. Clin Infect Dis. 2019;69(2):341–4. doi:10.1093/cid/ciy953.
   PubMed Web of Science ®Google Scholar
• Tseng HF, Bruxvoort K, Ackerson B, Luo Y, Tanenbaum H, Tian Y, Zheng C, Cheung B, Patterson BJ, Van Oorschot D. et al. The epidemiology of herpes zoster in immunocompetent, unvaccinated adults ≥50 years old: incidence, complications, hospitalization, mortality, and recurrence. J Infect Dis. 2020;222(5):798–806. doi:10.1093/infdis/jiz652.
   PubMed Web of Science ®Google Scholar
• Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833. doi:10.1136/bmjopen-2014-004833.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Liu X, Suo L, Zhao D, Pan J, Lu L. The incidence of herpes zoster in China: a meta-analysis and evidence quality assessment. Hum Vaccin Immunother. 2023;19(2):2228169. doi:10.1080/21645515.2023.2228169.
   PubMed Web of Science ®Google Scholar
• Harpaz R, Leung JW. The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among children. Clin Infect Dis. 2019;69(2):345–7. doi:10.1093/cid/ciy954.
   PubMed Web of Science ®Google Scholar
• Hales CM, Harpaz R, Bialek SR. Self-reported herpes zoster, pain, and health care seeking in the health and retirement study: implications for interpretation of health care-based studies. Ann Epidemiol. 2016;26(6):441–6.e443. doi:10.1016/j.annepidem.2016.04.006.
   PubMed Web of Science ®Google Scholar
• Harpaz R. How little we know herpes zoster. J Infect Dis. 2020;222(5):708–11. doi:10.1093/infdis/jiz653.
   PubMed Web of Science ®Google Scholar
• Strezova A, Diez-Domingo J, Al Shawafi K, Tinoco JC, Shi M, Pirrotta P, Mwakingwe-Omari A, Zoster-049 Study Group. Long-term protection against herpes zoster by the adjuvanted recombinant zoster vaccine: interim efficacy, immunogenicity, and safety results up to 10 years after initial vaccination. Open Forum Infect Dis. 2022;9(10):ofac485. doi:10.1093/ofid/ofac485.
   PubMed Web of Science ®Google Scholar
• Zerbo O, Bartlett J, Fireman B, Lewis N, Goddard K, Dooling K, Duffy J, Glanz J, Naleway A, Donahue JG. et al. Effectiveness of recombinant zoster vaccine against herpes zoster in a real-world setting. Ann Intern Med. 2024;177(2):189–95. doi:10.7326/m23-2023.
   PubMed Web of Science ®Google Scholar
• Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K, Bialek SR, Marin M. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. J Infect Dis. 2013;208(11):1859–68. doi:10.1093/infdis/jit405.
   PubMed Web of Science ®Google Scholar
• Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, Seward JF. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J. 2009;28(11):954–9. doi:10.1097/INF.0b013e3181a90b16.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Itzler RF, Wollan PC, Pellissier JM, Sy LS, Saddier P. Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc. 2009;84(9):787–94. doi:10.4065/84.9.787.
   PubMed Web of Science ®Google Scholar
• Yawn BP. Post-shingles neuralgia by any definition is painful, but is it PHN? Mayo Clin Proc. 2011;86(12):1141–2. doi:10.4065/mcp.2011.0724.
   PubMed Web of Science ®Google Scholar
• Turner HC, Lauer JA, Tran BX, Teerawattananon Y, Jit M. Adjusting for inflation and currency changes within health economic studies. Value Health. 2019;22(9):1026–32. doi:10.1016/j.jval.2019.03.021.
   PubMed Web of Science ®Google Scholar
• Kawahira K, Imano H, Yamada K, Takao Y, Mori Y, Asada H, Okuno Y, Yamanishi K, Iso H. Risk of herpes zoster in relation to body mass index among residents aged ≥50 years: the Shozu herpes zoster study. J Epidemiol. 2022;32(8):370–5. doi:10.2188/jea.JE20200473.
   PubMed Web of Science ®Google Scholar
• Kobayashi D, Shimbo T, Noto H, Eto H, Takahashi O, Higuchi T. Low level of hemoglobin A1c and the increased incidence of herpes zoster: longitudinal study. Eur J Clin Microbiol Infect Dis. 2019;38(8):1539–45. doi:10.1007/s10096-019-03584-1.
   PubMed Web of Science ®Google Scholar
• Ha JW, Lee JY, Her Y, Kim CW, Kim SS. Frequency of herpes zoster recurrence in central district of Korea. Ann Dermatol. 2017;29(5):602–7. doi:10.5021/ad.2017.29.5.602.
   PubMed Web of Science ®Google Scholar
• Cho SI, Lee DH, Park YM. Identification of herpes zoster high-risk group using Charlson comorbidity index: a nationwide retrospective cohort study. J Dermatol. 2020;47(1):47–53. doi:10.1111/1346-8138.15115.
   PubMed Web of Science ®Google Scholar
• Wan EYF, Chui CSL, Wang Y, Ng VWS, Yan VKC, Lai FTT, Li X, Wong CKH, Chan EWY, Wong CSM. et al. Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: a self-controlled case series and nested case-control study. Lancet Reg Health West Pac. 2022;21:100393. doi:10.1016/j.lanwpc.2022.100393.
   PubMedGoogle Scholar